AIM: To screen a suspected Hungarian HNPCC family to find specific mutations and to evaluate their effect on the presentation of the disease. METHODS: The family was identified by applying the Amsterdam and Bethesda Criteria. Immunohistochemistry was performed, and DNA samples isolated from tumor tissue were evaluated for microsatellite instability. The identification of possible mutations was carried out by sequencing the hMLH1 and hMSH2 genes. RESULTS: Two different mutations were observed in the index patient and in his family members. The first mutation was located in exon 7, codon 422 of hMSH2, and caused a change from Glu to STOP codon. No other report of such a mutation has been published, as far as we could find in the international databases. The second mutation was found in exon 3 codon 127 of the hMSH2 gene, resulting in Asp-->Ser substitution. The second mutation was already published, as a non-pathogenic allelic variation. CONCLUSION: The pedigree analysis suggested that the newly detected nonsense mutation in exon 7 of the hMSH2 gene might be responsible for the development of colon cancers. In family members where the exon 7 mutation is not coupled with this missense mutation, colon cancer appears after the age of 40. The association of these two mutations seems to decrease the age of manifestation of the disease into the early thirties.
AIM: To screen a suspected Hungarian HNPCC family to find specific mutations and to evaluate their effect on the presentation of the disease. METHODS: The family was identified by applying the Amsterdam and Bethesda Criteria. Immunohistochemistry was performed, and DNA samples isolated from tumor tissue were evaluated for microsatellite instability. The identification of possible mutations was carried out by sequencing the hMLH1 and hMSH2 genes. RESULTS: Two different mutations were observed in the index patient and in his family members. The first mutation was located in exon 7, codon 422 of hMSH2, and caused a change from Glu to STOP codon. No other report of such a mutation has been published, as far as we could find in the international databases. The second mutation was found in exon 3 codon 127 of the hMSH2 gene, resulting in Asp-->Ser substitution. The second mutation was already published, as a non-pathogenic allelic variation. CONCLUSION: The pedigree analysis suggested that the newly detected nonsense mutation in exon 7 of the hMSH2 gene might be responsible for the development of colon cancers. In family members where the exon 7 mutation is not coupled with this missense mutation, colon cancer appears after the age of 40. The association of these two mutations seems to decrease the age of manifestation of the disease into the early thirties.
Authors: W S Samowitz; K Curtin; H H Lin; M A Robertson; D Schaffer; M Nichols; K Gruenthal; M F Leppert; M L Slattery Journal: Gastroenterology Date: 2001-10 Impact factor: 22.682
Authors: D Calistri; S Presciuttini; G Buonsanti; P Radice; I Gazzoli; V Pensotti; P Sala; M Eboli; S Andreola; A Russo; M Pierotti; L Bertario; G N Ranzani Journal: Int J Cancer Date: 2000-01-20 Impact factor: 7.396
Authors: H J Järvinen; M Aarnio; H Mustonen; K Aktan-Collan; L A Aaltonen; P Peltomäki; A De La Chapelle; J P Mecklin Journal: Gastroenterology Date: 2000-05 Impact factor: 22.682
Authors: A Loukola; K Eklin; P Laiho; R Salovaara; P Kristo; H Järvinen; J P Mecklin; V Launonen; L A Aaltonen Journal: Cancer Res Date: 2001-06-01 Impact factor: 12.701
Authors: László Czakó; László Tiszlavicz; Róbert Takács; Gellért Baradnay; János Lonovics; Gábor Cserni; Katarina Závodná; Zdena Bartosova Journal: Orv Hetil Date: 2005-05-15 Impact factor: 0.540
Authors: Lise Lotte Christensen; Reetta Kariola; Mari K Korhonen; Friedrik P Wikman; Lone Sunde; Anne-Marie Gerdes; Henrik Okkels; Carsten A Brandt; Inge Bernstein; Thomas V O Hansen; Rikke Hagemann-Madsen; Claus L Andersen; Minna Nyström; Torben F Ørntoft Journal: Fam Cancer Date: 2009-08-21 Impact factor: 2.375
Authors: Miklós Tanyi; Judit Olasz; Janos L Tanyi; László Tóth; Péter Antal-Szalmás; Tamás Bubán; Csilla András; Hilda Urbancsek; Zoltán Garami; Orsolya Csuka; László Damjanovich Journal: Fam Cancer Date: 2012-09 Impact factor: 2.375
Authors: Jukka Kantelinen; Minttu Kansikas; Satu Candelin; Heather Hampel; Betsy Smith; Liisa Holm; Reetta Kariola; Minna Nyström Journal: Hum Mutat Date: 2012-06-11 Impact factor: 4.878
Authors: Juan M Marqués-Lespier; Yaritza Diaz-Algorri; Maria Gonzalez-Pons; Marcia Cruz-Correa Journal: Gastroenterol Res Pract Date: 2014-10-20 Impact factor: 2.260
Authors: Lise Lotte Christensen; Bo E Madsen; Friedrik P Wikman; Carsten Wiuf; Karen Koed; Anne Tjønneland; Anja Olsen; Ann-Christine Syvänen; Claus L Andersen; Torben F Orntoft Journal: BMC Med Genet Date: 2008-06-11 Impact factor: 2.103